Research Status and Trends of Cohort Studies on Efficacy Evaluation of Traditional Chinese Medicine：A Bibliometrix-based Visual Analysis on Literature from 2017 to 2022
10.13288/j.11-2166/r.2024.07.013
- VernacularTitle:基于Bibliometrix分析2017—2022年国内外中医药疗效评价队列研究的现状与趋势
- Author:
Zilin LONG
1
;
Houyu ZHAO
1
;
Xing LIAO
2
;
Junchang LIU
3
;
Qi SUN
4
;
Cheng WANG
4
;
Yutong FEI
5
;
Haibo SONG
6
;
Siyan ZHAN
1
;
Feng SUN
1
Author Information
1. Department of Epidemiology and Biostatistics， School of Public Health， Peking University & Key Laboratory of Epidemiology of Major Diseases， Ministry of Education， Beijing， 100191
2. Institute of Basic Research in Clinical Medicine， China Academy of Chinese Medical Sciences
3. Xinjiang Medical University Institute of Traditional Chinese Medicine
4. Traditional Chinese Medical Hospital of Xinjiang Uygur Autonomous Region
5. School of Traditional Chinese Medicine， Beijing University of Chinese Medicine
6. Key Laboratory of Pharmacovigilance Research and Evaluation， National Medical Products Administration
- Publication Type:Journal Article
- Keywords:
traditional Chinese medicine therapy;
cohort study;
efficacy evaluation;
Bibliometrix;
bibliometrics
- From:
Journal of Traditional Chinese Medicine
2024;65(7):737-744
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the research status and trends of cohort studies on traditional Chinese medicine （TCM） efficacy evaluation from 2017 to 2022 and provide ideas and references for research in this field. MethodsSix databases including Pubmed， Web of Science， Embase， Scopus， Cochrane Library and CNKI were searched from January 1st， 2017 to December 31st， 2022. The total number of annual publications， journals， highly cited literatures， and keywords were quantitatively and visually analyzed by Bibliometrix. ResultsA total of 328 articles were included， which were published in 141 journals. The number of articles published in this field showed an overall upward trend， and retrospective cohort studies （282 papers， 85.98%） accounted for the largest proportion. A total of 151 cohort studies （46.04%） were conducted based on the database and showed an overall upward trend. The subjects were mainly patients with tumors （77 papers， 23.48%）， and cardiovascular and cerebrovascular diseases （64 papers， 19.51%）. The top 3 highly cited literatures mainly explore the association between TCM and survival outcome and quality of life in patients with malignant tumors. Fourteen and twenty-five high-frequency keywords were included in Chinese and English literature respectively， which formed 3 clusters such as research methods， statistical analysis and diseases. ConclusionIt was the current status to focus on retrospective cohort studies and focus on patients with tumors or cardiovascular and cerebrovascular diseases. Using observational database to conduct cohort studies of TCM efficacy evaluation could be the future research direction.
